Robbins Andrew R 4
4 · Harpoon Therapeutics, Inc. · Filed Jun 24, 2022
Insider Transaction Report
Form 4
Robbins Andrews R
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-06-22+10,167→ 10,167 totalExercise: $2.01Exp: 2032-06-21→ Common Stock (10,167 underlying)
Footnotes (1)
- [F1]The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.